Putin urges new Marshall Plan for Middle East to see recovery and growthRussian Politics & Diplomacy October 27, 17:30
Zakharova slams Latvia’s crusade against historical memory as harmful to kids’ educationRussian Politics & Diplomacy October 27, 17:22
Russian diplomat rejects Kiev reports on armed police mission in DonbassRussian Politics & Diplomacy October 27, 17:07
Lavrov: Russian leaders need no one’s permission to visit CrimeaRussian Politics & Diplomacy October 27, 17:03
Vladimir Putin at Valdai Club session in Sochi: live streamRussian Politics & Diplomacy October 27, 16:36
NATO battalion at Russian border to get German tanks — defense ministryMilitary & Defense October 27, 16:31
Foreign Ministry offers consular assistance to Russian detained in PhilippinesRussian Politics & Diplomacy October 27, 16:08
Russian, Chinese, and Saudi physicists sharpen vision of photodetectorsScience & Space October 27, 16:02
Russian diplomat concerned over worsening situation in MosulRussian Politics & Diplomacy October 27, 15:57
ST. PETERSBURG, January 20. /TASS/. The US pharmaceuticals producer Pfizer will launch a joint production with St. Petersburg-based scientific and technological pharmaceutical company Polysan, a source familiar with the matter told TASS, adding that the sides are expected to sign the agreement in end-January.
"In end-January an agreement will be signed on production of Pfizer medicines in St. Petersburg and its localization. At the same time a joint production with Polysan pharm producer will be announced," the source said.
An official in St. Petersburg confirmed to TASS such an agreement is being prepared, saying that the signing is planned for January 25.
A representative of Polysan said when commenting the information that the company’s policy "is aimed at development of local pharmaceutical industry, including via cooperation with leading global pharma producers."
Polysan has manufacturing plants in St. Petersburg and Belgorod. In St. Petersburg, the company produces 4 its own brands of medicines, as well as a neurological drug within partnership with German Stada. In 2015, Polysan signed a 10-year agreement with German pharmaceuticals giant Bayer.
Polysan products are supplied to all regions in Russia, to the former CIS countries, South East Asia, Latin America and Mongolia.